Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announced today their participation in the Cellular Therapeutics in Trauma and Critical Care’s (CTTACC) conference, “Cellular Therapies and Tran...
Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced today their participation in The American Society for Neural Therapy... | April 21, 2023
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (Nasdaq: ATHX) today announced that it has closed its previously announced offering to sell 3,685,000 shares (the “Shares”) of the Company’s common stock (or common stock equivalents in lieu thereof) in a registered direct offering and warrants to purchase 3,685,000 Shares...
Athersys, Inc. today announced that it has entered into definitive agreements for the purchase and sale of 3,685,000 shares of the Company’s common stock in a registered direct offering and... | April 18, 2023
April 18, 2023 Athersys, Inc. Attention: Mr. Daniel Camardo 3201 Carnegie Avenue Cleveland, Ohio 44115 Dear Mr.... | April 18, 2023